A single, once-weekly tablet could change HIV treatment landscape; weight loss drug orforglipron efficacy assessed at all stages of menopause; hemophilia treatment Hympavzi gains expanded indication; ...

HUD requested public input on whether FHA minimum property requirements for single-family homes should be updated. Comments are due by June 29, and HUD is weighing repair conditions, reinspections and ...

MPR News host Angela Davis talks about new screening recommendations for cholesterol. High cholesterol is often treated with prescription medications known as statins, such as Pfizer's Lipitor ...

South Africa’s first attempt to establish a binding artificial intelligence (AI) policy framework came to an abrupt halt just 16 days after it was officially gazetted. On 10 April, the Department of ...

This Pew Research Center report looks at Americans’ views of the U.S. military action against Iran, which began in February 2026, as well as Americans’ confidence in Trump to make good decisions when ...

MPR’s Angela Davis has returned to the airwaves with the announcement that she is now cancer-free. Davis took a break from “MPR News with Angela Davis” starting in late August 2025, although it wasn’t ...

Section 1. Purpose. United States leadership in Artificial Intelligence (AI) will promote United States national and economic security and dominance across many domains. Pursuant to Executive Order ...

Minnesota Public Radio has announced the election of eight new members to its Board of Trustees. The board also elected Libby Hlavka as its new chair. Hlavka, who joined the MPR Board of Trustees in ...

What if you could delegate your most complex research tasks to an AI that not only understands your objectives but also plans, executes, and refines its approach with precision? Enter Gemini 3, a ...

This week, tech content creators began to suspect that AI was making it harder to share some of the most highly sought-after tech tutorials on YouTube, but now YouTube is denying that odd removals ...

Label changes for tranexamic acid; new approval for Tezspire; psychedelic gains Breakthrough Tx status for depression; oral semaglutide approved to reduce MACE risk in T2DM; Gazyva approved for lupus ...